Prevalence of thrombophilic gene polymorphisms in an Azari population of Iran

被引:8
作者
Bargahi, Nasrin [1 ]
Farajzadeh, Malak [1 ]
Poursadegh-Zonouzi, Ahmad [2 ]
Farajzadeh, Davoud [1 ,2 ]
机构
[1] Tabriz Univ Med Sci, Biotechnol Res Ctr, Dept Genet, Res & Dev Complex, Tabriz, Iran
[2] Azarbaijan Shahid Madani Univ, Fac Biol Sci, Dept Cellular & Mol Biol, Tabriz, Iran
关键词
thromboembolism; Factor V; prothrombin; plasminogen activator inhibitor-1;
D O I
10.4081/hr.2014.5321
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is several evidence suggests that thrombophilic gene polymorphisms may influence susceptibility to thromboembolic events. The prevalence of these polymorphisms is different in various races and ethnics. Accordingly, we studied the prevalence of Factor V (G1691A and A4070G), prothrombin G20210A and PAI-1 4G/ 5G in healthy northwest population of Iran. In this prospective study, 500 healthy individuals, who had no history of both personal and family history of thromboembolic disorders, were selected as a sample of healthy population in northwestern Iran. Genotyping of these polymorphisms was performed using the amplification refractory mutation system-polymerase chain reaction method. No significant differences were detected between the expected and observed frequencies of FV G1691A and A4070G, prothrombin G20210A polymorphisms (P> 0.05), while the expected frequency of 4G allele was significantly more than observed frequency in the studied population (P< 0.01). These findings were compared with other reports from various populations. In conclusion, the allele frequency for FV G1691A and PAI-1 4G/ 5G polymorphisms showed relative consistency compared to those of previous studies, while the incidence pattern of FV A4070G polymorphism in Northwestern population of Iran showed conflicting results regarding other studied population. The prothrombin G20210A polymorphism was observed at a higher frequency than other studied populations.
引用
收藏
页码:16 / 18
页数:3
相关论文
共 16 条
[1]  
Angchaisuksiri P, 2000, AM J HEMATOL, V65, P119, DOI 10.1002/1096-8652(200010)65:2<119::AID-AJH5>3.3.CO
[2]  
2-#
[3]   Association of the prothrombin G20210A mutation with factor V Leiden in a Midwestern American population [J].
Bavikatty, NR ;
Killeen, AA ;
Akel, N ;
Normolle, D ;
Schmaier, AH .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (02) :272-275
[4]   The prothrombin gene G20210A variant: Prevalence in a UK anticoagulant clinic population [J].
Cumming, AM ;
Keeney, S ;
Salden, A ;
Bhavnani, M ;
Shwe, KH ;
Hay, CRM .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (02) :353-355
[5]   Prevalence of factor V G1691A (Factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population [J].
Finan, RR ;
Tamim, H ;
Ameen, G ;
Sharida, HE ;
Rashid, M ;
Almawi, WY .
AMERICAN JOURNAL OF HEMATOLOGY, 2002, 71 (04) :300-305
[6]  
Frances F, 2006, REV MED CHILE, V134, P13
[7]   Plasminogen activator inhibitor-1 (PAI-1) 4 G/5 G polymorphism and endometrial cancer. Influence of PAI-1 polymorphism on tissue PAI-1 antigen and mRNA expression and tumor severity [J].
Gilabert-Estelles, Juan ;
Ramon, Luis A. ;
Braza-Boils, Aitana ;
Gilabert, Juan ;
Chirivella, Melitina ;
Espana, Francisco ;
Estelles, Amparo .
THROMBOSIS RESEARCH, 2012, 130 (02) :242-247
[8]   Screening for multiple hereditary hypercoagulability factors using the amplification refractory mutation system [J].
Hoppe, B ;
Heymann, GA ;
Koscielny, J ;
Hellstern, P ;
Kiesewetter, H ;
Salama, A .
THROMBOSIS RESEARCH, 2003, 111 (1-2) :115-120
[9]   HR2 haplotype in Arab population and patients with venous thrombosis in Kuwait [J].
Jadaon, MM ;
Dashti, AAR .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (07) :1467-1471
[10]   Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population [J].
Lu, YH ;
Zhao, YF ;
Liu, GH ;
Wang, XL ;
Liu, ZO ;
Chen, BP ;
Hui, RT .
THROMBOSIS RESEARCH, 2002, 106 (01) :7-12